Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis. [PDF]
Monreal E +10 more
europepmc +1 more source
Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes <i>GLB1</i>, <i>SLC6A3</i>, <i>SLC30A10</i>, <i>SLC39A14</i>, and <i>PLA2G6</i>: MDSGene Systematic Review. [PDF]
Rodriguez-Antiguedad J +25 more
europepmc +1 more source
Cognitive function is associated with the progression of non-tremor motor symptoms in Parkinson's disease. [PDF]
Gibbs MC +4 more
europepmc +1 more source
Body Fluid-based Biomarkers for Cognitive Impairment in Parkinson's Disease. [PDF]
R R +6 more
europepmc +1 more source
Beyond lines of treatment: embracing early high-efficacy disease-modifying treatments for multiple sclerosis management. [PDF]
Oreja-Guevara C +26 more
europepmc +1 more source
Economic burden of secondary progressive multiple sclerosis: DISCOVER study. [PDF]
Oreja-Guevara C +37 more
europepmc +1 more source
Comparison of post-earthquake trauma and anxiety levels of intensive care unit nurses and inpatient unit nurses: a cross-sectional study. [PDF]
Kilinç Z +3 more
europepmc +1 more source
Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline. [PDF]
Rodríguez-Antigüedad J +42 more
europepmc +1 more source
[Translation and cross-cultural adaptation to the Iceland-Family Perceived Support Questionnaire to the Spanish context]. [PDF]
Benbelkheir Núñez B +4 more
europepmc +1 more source

